ArticleOncology reports2022

Kinesin family member 2A acts as a potential prognostic marker and treatment target via interaction with PI3K/AKT and RhoA/ROCK pathways in acute myeloid leukemia.

Xinglin Liang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.